Dextera Biosciences Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 8

Dextera Biosciences General Information

Description

Developer of a biotechnology platform intended to develop new classes of protein-based therapeutics. The company's platform offers new drug entities that are non-immunogenic and inherently resistant to proteolysis, vastly improving pharmacokinetics that precisely target the site of disease while remaining invisible to the rest of the body, enabling patients to receive therapeutics to recover from chronic diseases.

Contact Information

Website
www.dexterabio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2630 Bancroft Way
  • Berkeley, CA 94704
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Life Sciences
Corporate Office
  • 2630 Bancroft Way
  • Berkeley, CA 94704
  • United States
+1 (650)

Dextera Biosciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dextera Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 01-Oct-2025 Completed Pre-Clinical Trials
5. Accelerator/Incubator 01-Jul-2024 Completed Pre-Clinical Trials
4. Restart - Later VC 01-Sep-2023 Completed Restart
3. Seed Round 30-Nov-2011 Completed Startup
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 01-Jan-2008 Completed Startup
To view Dextera Biosciences’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Dextera Biosciences Patents

  • 23

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Dextera Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3941580-A1 D-peptidic compounds for vegf Pending 22-Mar-2019
JP-2022082754-A D-peptidic compounds for vegf Inactive 22-Mar-2019
JP-2024149556-A D-peptidic compounds for vegf Pending 22-Mar-2019
US-20210061861-A1 D-peptidic compounds for vegf Inactive 22-Mar-2019
WO-2020198074-A1 D-peptidic compounds for vegf Inactive 22-Mar-2019 C07K16/22
To view Dextera Biosciences’s complete patent history, request access »

Dextera Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dextera Biosciences Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
BEVC (Berkeley) Venture Capital Minority
Angel (individual) Minority
Angel (individual) Minority
Third Eye Asset Management Asset Manager Minority
QB3 Accelerator/Incubator
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Dextera Biosciences FAQs

  • When was Dextera Biosciences founded?

    Dextera Biosciences was founded in 2008.

  • Where is Dextera Biosciences headquartered?

    Dextera Biosciences is headquartered in Berkeley, CA.

  • What is the size of Dextera Biosciences?

    Dextera Biosciences has 14 total employees.

  • What industry is Dextera Biosciences in?

    Dextera Biosciences’s primary industry is Drug Discovery.

  • Is Dextera Biosciences a private or public company?

    Dextera Biosciences is a Private company.

  • What is Dextera Biosciences’s current revenue?

    The current revenue for Dextera Biosciences is .

  • How much funding has Dextera Biosciences raised over time?

    Dextera Biosciences has raised $18M.

  • Who are Dextera Biosciences’s investors?

    BEVC (Berkeley), , , Third Eye Asset Management, and QB3 are 5 of 8 investors who have invested in Dextera Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process